Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Oct;87(19):7438–7442. doi: 10.1073/pnas.87.19.7438

Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient.

D Mathez 1, D Paul 1, C de Bélilovsky 1, Y Sultan 1, J Deleuze 1, I Gorin 1, W Saurin 1, R Decker 1, J Leibowitch 1
PMCID: PMC54762  PMID: 2217174

Abstract

Mononuclear cells were obtained from 71 human immunodeficiency virus type 1 (HIV-1) seropositive subjects presenting and first visit either as asymptomatic or with minor symptoms and with CD4 lymphocytes greater than 550 per mm3 (group A, 35 patients) or as patients with AIDS, AIDS-related illnesses, or CD4 lymphocytes less than 400 per mm3 (group B, 36 patients). After 1-5 years of follow-up, 13 patients of group A had essentially retained their initial status (asymptomatics); the 22 others had suffered clinical or immunological deterioration (progressors). Frozen cells were thawed and submitted to lethal gamma-irradiation in vitro (4500 rads; 1 rad = 0.01 Gy) before they were cultured with normal phytohemagglutinin-stimulated lymphocytes to determine radiation-resistant HIV expression ex vivo (R-HEV). HIV antigenemia correlated with R-HEV values in 142 samples (r = 0.92, P less than 0.001) but was a less sensitive predictor of disease than R-HEV. R-HEV was detected in all specimens from patients with major AIDS-related illnesses or HIV-associated CD4 lymphopenia. In 77% of the progressors from group A, R-HEV detection preceded the onset of AIDS-associated disease or CD4 lymphopenia by 1 year (average). Conversely, R-HEV was low or was not detected in 36 sequential specimens from the 13 patients who remained asymptomatic over the following 2-5 years. Thus, persistently low HIV expression in vivo predicted a nondiseased state, whereas higher HIV expression levels seemed necessary for disease to occur. These data indicate that R-HEV is related to productive HIV infection in vivo, the latter acting as a determinant of AIDS-related illnesses. In view of this, measurement of HIV expression levels in the patient should be useful in antiviral efficacy trials.

Full text

PDF
7438

Images in this article

7440Image
on p.7440
7441Image
on p.7441
7441Image
on p.7441

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert J., Gaines H., Sönnerborg A., Nyström G., Pehrson P. O., Chiodi F., von Sydow M., Moberg L., Lidman K., Christensson B. Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol. 1987 Sep;23(1):67–73. doi: 10.1002/jmv.1890230108. [DOI] [PubMed] [Google Scholar]
  2. Allain J. P., Laurian Y., Paul D. A., Verroust F., Leuther M., Gazengel C., Senn D., Larrieu M. J., Bosser C. Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance. N Engl J Med. 1987 Oct 29;317(18):1114–1121. doi: 10.1056/NEJM198710293171804. [DOI] [PubMed] [Google Scholar]
  3. Andrews C. A., Sullivan J. L., Brettler D. B., Brewster F. E., Forsberg A. D., Scesney S., Levine P. H. Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalities. J Pediatr. 1987 Nov;111(5):672–677. doi: 10.1016/s0022-3476(87)80241-x. [DOI] [PubMed] [Google Scholar]
  4. Baillou A., Barin F., Allain J. P., Petat E., Kocheleff P., Kadende P., Goudeau A. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations. J Infect Dis. 1987 Nov;156(5):830–833. doi: 10.1093/infdis/156.5.830. [DOI] [PubMed] [Google Scholar]
  5. Broder S. Controlled trial methodology and progress in treatment of the acquired immunodeficiency syndrome (AIDS). A quid pro quo. Ann Intern Med. 1989 Mar 15;110(6):417–418. doi: 10.7326/0003-4819-110-6-417. [DOI] [PubMed] [Google Scholar]
  6. Chen U. Anti-IgM antibodies inhibit IgM expression in lipopolysaccharide-stimulated normal murine B-cells: study of RNA metabolism and translation. Gene. 1988 Dec 10;72(1-2):209–217. doi: 10.1016/0378-1119(88)90146-1. [DOI] [PubMed] [Google Scholar]
  7. Coombs R. W., Collier A. C., Allain J. P., Nikora B., Leuther M., Gjerset G. F., Corey L. Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 1989 Dec 14;321(24):1626–1631. doi: 10.1056/NEJM198912143212402. [DOI] [PubMed] [Google Scholar]
  8. Cory J. M., Ohlsson-Wilhelm B. M., Steck M. E., Smithgall M. D., Rozday V., Eyster M. E., Rapp F. Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units. AIDS Res Hum Retroviruses. 1989 Feb;5(1):97–106. doi: 10.1089/aid.1989.5.97. [DOI] [PubMed] [Google Scholar]
  9. Duesberg P. H. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc Natl Acad Sci U S A. 1989 Feb;86(3):755–764. doi: 10.1073/pnas.86.3.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ehrnst A., Sönnerborg A., Bergdahl S., Strannegård O. Efficient isolation of HIV from plasma during different stages of HIV infection. J Med Virol. 1988 Sep;26(1):23–32. doi: 10.1002/jmv.1890260105. [DOI] [PubMed] [Google Scholar]
  11. Falk L. A., Jr, Paul D., Landay A., Kessler H. HIV isolation from plasma of HIV-infected persons. N Engl J Med. 1987 Jun 11;316(24):1547–1548. doi: 10.1056/NEJM198706113162413. [DOI] [PubMed] [Google Scholar]
  12. Folks T., Powell D. M., Lightfoote M. M., Benn S., Martin M. A., Fauci A. S. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. Science. 1986 Feb 7;231(4738):600–602. doi: 10.1126/science.3003906. [DOI] [PubMed] [Google Scholar]
  13. Gaines H., Albert J., von Sydow M., Sönnerborg A., Chiodi F., Ehrnst A., Strannegård O., Asjö B. HIV antigenaemia and virus isolation from plasma during primary HIV infection. Lancet. 1987 Jun 6;1(8545):1317–1318. doi: 10.1016/s0140-6736(87)90570-8. [DOI] [PubMed] [Google Scholar]
  14. Goudsmit J., Lange J. M., Paul D. A., Dawson G. J. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. J Infect Dis. 1987 Mar;155(3):558–560. doi: 10.1093/infdis/155.3.558. [DOI] [PubMed] [Google Scholar]
  15. Goudsmit J., de Wolf F., Paul D. A., Epstein L. G., Lange J. M., Krone W. J., Speelman H., Wolters E. C., Van der Noordaa J., Oleske J. M. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 1986 Jul 26;2(8500):177–180. doi: 10.1016/s0140-6736(86)92485-2. [DOI] [PubMed] [Google Scholar]
  16. Hirsch M. S., Phillips S. M., Solnik C., Black P. H., Schwartz R. S., Carpenter C. B. Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A. 1972 May;69(5):1069–1072. doi: 10.1073/pnas.69.5.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ho D. D., Moudgil T., Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med. 1989 Dec 14;321(24):1621–1625. doi: 10.1056/NEJM198912143212401. [DOI] [PubMed] [Google Scholar]
  18. Imagawa D. T., Lee M. H., Wolinsky S. M., Sano K., Morales F., Kwok S., Sninsky J. J., Nishanian P. G., Giorgi J., Fahey J. L. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med. 1989 Jun 1;320(22):1458–1462. doi: 10.1056/NEJM198906013202205. [DOI] [PubMed] [Google Scholar]
  19. Kaplan J. E., Spira T. J., Feorino P. M., Warfield D. T., Fishbein D. B. HTLV-III viremia in homosexual men with generalized lymphadenopathy. N Engl J Med. 1985 Jun 13;312(24):1572–1573. doi: 10.1056/NEJM198506133122412. [DOI] [PubMed] [Google Scholar]
  20. Lange J. M., Paul D. A., Huisman H. G., de Wolf F., van den Berg H., Coutinho R. A., Danner S. A., van der Noordaa J., Goudsmit J. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1459–1462. doi: 10.1136/bmj.293.6560.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Makuch R. W., Parks W. P. Statistical methods for the analysis of HIV-1 core polypeptide antigen data in clinical studies. AIDS Res Hum Retroviruses. 1988 Aug;4(4):305–316. doi: 10.1089/aid.1988.4.305. [DOI] [PubMed] [Google Scholar]
  22. Mathez D., Leibovitch J., Sultan Y., Maisonneuve P. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France. N Engl J Med. 1986 Jan 9;314(2):118–119. doi: 10.1056/NEJM198601093140213. [DOI] [PubMed] [Google Scholar]
  23. McElrath M. J., Pruett J. E., Cohn Z. A. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc Natl Acad Sci U S A. 1989 Jan;86(2):675–679. doi: 10.1073/pnas.86.2.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nicholson J. K., Spira T. J., Aloisio C. H., Jones B. M., Kennedy M. S., Holman R. C., McDougal J. S. Serial determinations of HIV-1 titers in HIV-infected homosexual men: association of rising titers with CD4 T cell depletion and progression to AIDS. AIDS Res Hum Retroviruses. 1989 Apr;5(2):205–215. doi: 10.1089/aid.1989.5.205. [DOI] [PubMed] [Google Scholar]
  25. Oldstone M. B. Viral persistence. Cell. 1989 Feb 24;56(4):517–520. doi: 10.1016/0092-8674(89)90573-4. [DOI] [PubMed] [Google Scholar]
  26. Paul D. A., Falk L. A., Kessler H. A., Chase R. M., Blaauw B., Chudwin D. S., Landay A. L. Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol. 1987 Aug;22(4):357–363. doi: 10.1002/jmv.1890220408. [DOI] [PubMed] [Google Scholar]
  27. Ratner L. Measurement of human immunodeficiency virus load and its relation to disease progression. AIDS Res Hum Retroviruses. 1989 Apr;5(2):115–119. doi: 10.1089/aid.1989.5.115. [DOI] [PubMed] [Google Scholar]
  28. Rosenberg Z. F., Fauci A. S. Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses. 1989 Feb;5(1):1–4. doi: 10.1089/aid.1989.5.1. [DOI] [PubMed] [Google Scholar]
  29. Schnittman S. M., Psallidopoulos M. C., Lane H. C., Thompson L., Baseler M., Massari F., Fox C. H., Salzman N. P., Fauci A. S. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science. 1989 Jul 21;245(4915):305–308. doi: 10.1126/science.2665081. [DOI] [PubMed] [Google Scholar]
  30. Simmonds P., Lainson F. A., Cuthbert R., Steel C. M., Peutherer J. F., Ludlam C. A. HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort. Br Med J (Clin Res Ed) 1988 Feb 27;296(6622):593–598. doi: 10.1136/bmj.296.6622.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Stanley S. K., Folks T. M., Fauci A. S. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses. 1989 Aug;5(4):375–384. doi: 10.1089/aid.1989.5.375. [DOI] [PubMed] [Google Scholar]
  32. Tsiquaye K. N., Youle M., Chanas A. C. Restriction of sensitivity of HIV-1-antigen ELISA by serum anti-core antibodies. AIDS. 1988 Feb;2(1):41–45. doi: 10.1097/00002030-198802000-00007. [DOI] [PubMed] [Google Scholar]
  33. Valerie K., Delers A., Bruck C., Thiriart C., Rosenberg H., Debouck C., Rosenberg M. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature. 1988 May 5;333(6168):78–81. doi: 10.1038/333078a0. [DOI] [PubMed] [Google Scholar]
  34. Walker C. M., Moody D. J., Stites D. P., Levy J. A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986 Dec 19;234(4783):1563–1566. doi: 10.1126/science.2431484. [DOI] [PubMed] [Google Scholar]
  35. Wittek A. E., Phelan M. A., Wells M. A., Vujcic L. K., Epstein J. S., Lane H. C., Quinnan G. V., Jr Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion. Ann Intern Med. 1987 Sep;107(3):286–292. doi: 10.7326/0003-4819-107-2-286. [DOI] [PubMed] [Google Scholar]
  36. Zagury D., Bernard J., Leonard R., Cheynier R., Feldman M., Sarin P. S., Gallo R. C. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 1986 Feb 21;231(4740):850–853. doi: 10.1126/science.2418502. [DOI] [PubMed] [Google Scholar]
  37. de Wolf F., Goudsmit J., Paul D. A., Lange J. M., Hooijkaas C., Schellekens P., Coutinho R. A., van der Noordaa J. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. Br Med J (Clin Res Ed) 1987 Sep 5;295(6598):569–572. doi: 10.1136/bmj.295.6598.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. van den Akker R., Bouman-van Engelen C. A., de Jong J. C., Dolmans W. M., van Loon A. M., Mulder D. W., Shao J. F. Persistence of anti-HIV p24 antibodies in African AIDS patient. AIDS. 1988 Feb;2(1):62–63. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES